Cyclin T1 inhibitors are a class of chemical compounds designed to target and modulate the activity of cyclin T1, a protein that plays a crucial role in the regulation of transcription processes. Cyclin T1 is a component of the positive transcription elongation factor b (P-TEFb) complex, which is essential for facilitating the transition of RNA polymerase II from transcription initiation to elongation. This transition is a pivotal step in gene expression regulation, as it determines the rate of transcription and ultimately influences the synthesis of proteins involved in various cellular functions.
The inhibitors within this class are developed with a specific focus on disrupting the interactions and activities of cyclin T1, altering the transcriptional elongation process. By selectively targeting cyclin T1, these compounds provide researchers with a valuable tool to investigate the intricate mechanisms of transcription regulation and its impact on cellular processes. The study of cyclin T1 inhibitors offers insights into the complex interplay between transcription factors, co-factors, and RNA polymerase, contributing to a better understanding of gene expression control and its relevance in various biological contexts.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
CDK inhibitor targeting Cyclin T1-dependent kinase CDK9, disrupting transcription elongation by inhibiting RNA Pol II. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $92.00 $260.00 | 42 | |
Competes with ATP for CDK9 binding, leading to transcriptional inhibition by RNA Pol II. | ||||||
Dinaciclib | 779353-01-4 | sc-364483 sc-364483A | 5 mg 25 mg | $242.00 $871.00 | 1 | |
Binds to CDK9's ATP-binding pocket, inhibiting kinase activity and RNA Pol II phosphorylation. | ||||||
AT7519 | 844442-38-2 | sc-364416 sc-364416A sc-364416B sc-364416C | 5 mg 10 mg 100 mg 1 g | $207.00 $246.00 $1025.00 $3065.00 | 1 | |
Impairs CDK9 kinase activity, resulting in RNA Pol II dephosphorylation and transcriptional suppression. | ||||||
SNS-032 | 345627-80-7 | sc-364621 sc-364621A | 5 mg 10 mg | $169.00 $262.00 | ||
Selective CDK9 inhibitor, binding to ATP site and hindering CDK9's ability to phosphorylate RNA Pol II. |